News
FDA: Krintafel approved as ‘radical cure’ for preventing malaria relapse
The FDA has approved single-dose tafenoquine (to be marketed as Krintafel) for the prevention of relapse in patients receiving appropriate...
Mark S. Lesney
The FDA has approved single-dose tafenoquine (to be marketed as Krintafel) for the prevention of relapse in patients receiving appropriate...